HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE
Go back to HALOZYME REPORTS RECORD SECOND QUARTER 2026 RESULTS, BEATS ESTIMATES AND RAISES FULL YEAR 2026 FINANCIAL GUIDANCE| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 110.19 -0.57 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.76 | 52 Week High | $18.39 | |||
| Open | $109.91 | 52 Week Low | $6.96 | |||
| Day High | $111.15 | P/E | N/A | |||
| Day Low | $109.00 | EPS | $-0.58 | |||
| Volume | 1,010,598 | |||||
